Natural Killer Cells and Cytotoxic T Cells: Complementary Partners against Microorganisms and Cancer von Vojdani, Aristo, Koksoy, Sadi, Vojdani, Elroy, Engelman, Mark, Benzvi, Carina, Lerner, Aaron

Volltext

Trade mark assignments—a continuing academic nightmare von Engelman, Mark

Volltext

Natural Killer Cells and Cytotoxic T Cells: Complementary Partners against Microorganisms and Cancer von Vojdani, Aristo, Koksoy, Sadi, Vojdani, Elroy, Engelman, Mark, Benzvi, Carina, Lerner, Aaron

Volltext

ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers von BERGETHON, Kristin, SHAW, Alice T, MARK, Eugene J, BATTEN, Julie M, HAIQUAN CHEN, WILNER, Keith D, KWAK, Eunice L, CLARK, Jeffrey W, CARBONE, David P, HONGBIN JI, ENGELMAN, Jeffrey A, MINO-KENUDSON, Mari, IGNATIUS OU, Sai-Hong, PAO, William, IAFRATE, A. John, KATAYAMA, Ryohei, LOVLY, Christine M, MCDONALD, Nerina T, MASSION, Pierre P, SIWAK-TAPP, Christina, GONZALEZ, Adriana, RONG FANG

Volltext

Patient-derived models of acquired resistance can identify effective drug combinations for cancer von Crystal, Adam S., Shaw, Alice T., Sequist, Lecia V., Friboulet, Luc, Niederst, Matthew J., Lockerman, Elizabeth L., Frias, Rosa L., Gainor, Justin F., Amzallag, Arnaud, Greninger, Patricia, Lee, Dana, Kalsy, Anuj, Gomez-Caraballo, Maria, Elamine, Leila, Howe, Emily, Hur, Wooyoung, Lifshits, Eugene, Robinson, Hayley E., Katayama, Ryohei, Faber, Anthony C., Awad, Mark M., Ramaswamy, Sridhar, Mino-Kenudson, Mari, Iafrate, A. John, Benes, Cyril H., Engelman, Jeffrey A.

Volltext

The ALK inhibitor ceritinib overcomes crizotinib resistance in non-small cell lung cancer von Friboulet, Luc, Li, Nanxin, Katayama, Ryohei, Lee, Christian C, Gainor, Justin F, Crystal, Adam S, Michellys, Pierre-Yves, Awad, Mark M, Yanagitani, Noriko, Kim, Sungjoon, Pferdekamper, AnneMarie C, Li, Jie, Kasibhatla, Shailaja, Sun, Frank, Sun, Xiuying, Hua, Su, McNamara, Peter, Mahmood, Sidra, Lockerman, Elizabeth L, Fujita, Naoya, Nishio, Makoto, Harris, Jennifer L, Shaw, Alice T, Engelman, Jeffrey A

Volltext

Clinical Definition of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer von JACKMAN, David, PAO, William, RIELY, Gregory J, ENGELMAN, Jeffrey A, KRIS, Mark G, JÄNNE, Pasi A, LYNCH, Thomas, JOHNSON, Bruce E, MILLER, Vincent A

Volltext

MicroRNA silencing for cancer therapy targeted to the tumour microenvironment von Cheng, Christopher J., Bahal, Raman, Babar, Imran A., Pincus, Zachary, Barrera, Francisco, Liu, Connie, Svoronos, Alexander, Braddock, Demetrios T., Glazer, Peter M., Engelman, Donald M., Saltzman, W. Mark, Slack, Frank J.

Volltext

Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1 von Ohashi, Kadoaki, Sequist, Lecia V, Arcila, Maria E, Moran, Teresa, Chmielecki, Juliann, Lin, Ya-Lun, Pan, Yumei, Wang, Lu, de Stanchina, Elisa, Shien, Kazuhiko, Aoe, Keisuke, Toyooka, Shinichi, Kiura, Katsuyuki, Fernandez-Cuesta, Lynnette, Fidias, Panos, Yang, James Chih-Hsin, Miller, Vincent A, Riely, Gregory J, Kris, Mark G, Engelman, Jeffrey A, Vnencak-Jones, Cindy L, Dias-Santagata, Dora, Ladanyi, Marc, Pao, William

Volltext

Relationship between HER-2 overexpression and brain metastasis in esophageal cancer patients von Abu Hejleh, Taher, Deyoung, Barry R, Engelman, Eric, Deutsch, Jeremy M, Zimmerman, Bridget, Halfdanarson, Thorvardur R, Berg, Daniel J, Parekh, Kalpaj R, Lynch, William R, Iannettoni, Mark D, Bhatia, Sudershan, Clamon, Gerald

Volltext

Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors von Miao, Diana, Margolis, Claire A., Vokes, Natalie I., Liu, David, Taylor-Weiner, Amaro, Wankowicz, Stephanie M., Adeegbe, Dennis, Keliher, Daniel, Schilling, Bastian, Tracy, Adam, Manos, Michael, Chau, Nicole G., Hanna, Glenn J., Polak, Paz, Rodig, Scott J., Signoretti, Sabina, Sholl, Lynette M., Engelman, Jeffrey A., Getz, Gad, Jänne, Pasi A., Haddad, Robert I., Choueiri, Toni K., Barbie, David A., Haq, Rizwan, Awad, Mark M., Schadendorf, Dirk, Hodi, F. Stephen, Bellmunt, Joaquim, Wong, Kwok-Kin, Hammerman, Peter, Van Allen, Eliezer M.

Volltext

Computational analysis of membrane proteins: the largest class of drug targets von Arinaminpathy, Yalini, Khurana, Ekta, Engelman, Donald M., Gerstein, Mark B.

Volltext

ALK rearrangements are mutually exclusive with mutations in EGFR or KRAS: an analysis of 1,683 patients with non-small cell lung cancer von Gainor, Justin F, Varghese, Anna M, Ou, Sai-Hong Ignatius, Kabraji, Sheheryar, Awad, Mark M, Katayama, Ryohei, Pawlak, Amanda, Mino-Kenudson, Mari, Yeap, Beow Y, Riely, Gregory J, Iafrate, A John, Arcila, Maria E, Ladanyi, Marc, Engelman, Jeffrey A, Dias-Santagata, Dora, Shaw, Alice T

Volltext

The Wisconsin Registry for Alzheimer's Prevention: A review of findings and current directions von Johnson, Sterling C., Koscik, Rebecca L., Jonaitis, Erin M., Clark, Lindsay R., Mueller, Kimberly D., Berman, Sara E., Bendlin, Barbara B., Engelman, Corinne D., Okonkwo, Ozioma C., Hogan, Kirk J., Asthana, Sanjay, Carlsson, Cynthia M., Hermann, Bruce P., Sager, Mark A.

Volltext

Assessment of ABT-263 activity across a cancer cell line collection leads to a potent combination therapy for small-cell lung cancer von Faber, Anthony C., Farago, Anna F., Costa, Carlotta, Dastur, Anahita, Gomez-Caraballo, Maria, Robbins, Rebecca, Wagner, Bethany L., Rideout, William M., Jakubik, Charles T., Ham, Jungoh, Edelman, Elena J., Ebi, Hiromichi, Yeo, Alan T., Hata, Aaron N., Song, Youngchul, Patel, Neha U., March, Ryan J., Tam, Ah Ting, Milano, Randy J., Boisvert, Jessica L., Hicks, Mark A., Elmiligy, Sarah, Malstrom, Scott E., Rivera, Miguel N., Harada, Hisashi, Windle, Brad E., Ramaswamy, Sridhar, Benes, Cyril H., Jacks, Tyler, Engelman, Jeffrey A.

Volltext

KLOTHO heterozygosity attenuates APOE4-related amyloid burden in preclinical AD von Erickson, Claire M, Schultz, Stephanie A, Oh, Jennifer M, Darst, Burcu F, Ma, Yue, Norton, Derek, Betthauser, Tobey, Gallagher, Catherine L, Carlsson, Cynthia M, Bendlin, Barbara B, Asthana, Sanjay, Hermann, Bruce P, Sager, Mark A, Blennow, Kaj, Zetterberg, Henrik, Engelman, Corinne D, Christian, Bradley T, Johnson, Sterling C, Dubal, Dena B, Okonkwo, Ozioma C

Volltext

Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer von Kwak, Eunice L, Bang, Yung-Jue, Camidge, D. Ross, Shaw, Alice T, Solomon, Benjamin, Maki, Robert G, Ou, Sai-Hong I, Dezube, Bruce J, Jänne, Pasi A, Costa, Daniel B, Varella-Garcia, Marileila, Kim, Woo-Ho, Lynch, Thomas J, Fidias, Panos, Stubbs, Hannah, Engelman, Jeffrey A, Sequist, Lecia V, Tan, WeiWei, Gandhi, Leena, Mino-Kenudson, Mari, Wei, Greg C, Shreeve, S. Martin, Ratain, Mark J, Settleman, Jeffrey, Christensen, James G, Haber, Daniel A, Wilner, Keith, Salgia, Ravi, Shapiro, Geoffrey I, Clark, Jeffrey W, Iafrate, A. John

Volltext

Statistical analysis of amino acid patterns in transmembrane helices: the GxxxG motif occurs frequently and in association with β-branched residues at neighboring positions von Senes, Alessandro, Gerstein, Mark, Engelman, Donald M

Volltext

Characteristics of Lung Cancers Harboring NRAS Mutations von OHASHI, Kadoaki, SEQUIST, Lecia V, YUMEI PAN, SASAKI, Hidefumi, ENGELMAN, Jeffrey A, GARON, Edward B, DUBINETT, Steven M, FRANKLIN, Wilbur A, RIELY, Gregory J, SOS, Martin L, KRIS, Mark G, DIAS-SANTAGATA, Dora, ARCILA, Maria E, LADANYI, Marc, BUNN, Paul A, PAO, William, LOVLY, Christine M, XI CHEN, RUDIN, Charles M, MORAN, Teresa, CAMIDGE, David Ross, VNENCAK-JONES, Cindy L, BERRY, Lynne

Volltext

Splanchnic nerve modulation in heart failure: mechanistic overview, initial clinical experience, and safety considerations von Fudim, Marat, Ponikowski, Piotr P., Burkhoff, Daniel, Dunlap, Mark E., Sobotka, Paul A., Molinger, Jeroen, Patel, Manesh R., Felker, G. Michael, Hernandez, Adrian F., Litwin, Sheldon E., Borlaug, Barry A., Bapna, Anisha, Sievert, Horst, Reddy, Vivek Y., Engelman, Zoar J., Shah, Sanjiv J.

Volltext